A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Daily News Roundup
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
The rise in the amount of federal money requested through research grants is due to a rise in the overall number of applicants.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
A trial comparing the effectiveness of robotic surgery and radiation for the treatment of throat cancer has begun in Canada.
The United Kingdom's Wellcome Trust announces that it will begin sanctioning researchers who do not submit manuscripts to the public UK PubMed Central database.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
A public interest legal group has renewed the fight against DNA patenting.